Europe Moves Closer to a New Hemophilia A Treatment Edited by Joyani Das

https://www.medscape.com/viewarticle/europe-moves-closer-new-hemophilia-treatment-2026a1000z33?src= Patients with hemophilia A in Europe may soon have a new, more flexible prophylactic option to prevent bleeding episodes. At its September meeting, the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorization for Frehemgo (denecimig; Novo Nordisk) for routine prophylaxis of bleeding episodes in patients with hemophilia A, including those: